Pulmonary Arterial Hypertension (PAH)

10 min prep · 15 min cook · Serves 2

Herb-Baked Salmon with Roasted Asparagus

This one's a crowd-pleaser. Omega-3s, minimal sodium, done in 25 minutes.

Why it works for Pulmonary Arterial Hypertension Omega-3s in salmon reduce triglycerides and lower heart disease risk. Asparagus provides folate and potassium for blood vessel health.

omega-3high-proteinlow-sodium

5 min prep · 10 min cook · Serves 1

Berry & Walnut Oatmeal

The breakfast that actually does something for your cholesterol. Not flashy — just effective.

Why it works for Pulmonary Arterial Hypertension Beta-glucan in oats is clinically shown to reduce LDL (bad) cholesterol. Walnuts add heart-protective plant-based omega-3s.

cholesterolfiberblood-sugar

15 min prep · 0 min cook · Serves 2

Mediterranean Chickpea Salad

A whole meal in a bowl. Protein, fiber, and good fats — no cooking required.

Why it works for Pulmonary Arterial Hypertension Mediterranean diet patterns consistently reduce cardiovascular risk. Olive oil, legumes, and vegetables are the foundation.

no-cookhigh-fiberplant-based

10 min prep · 25 min cook · Serves 4

Garlic-Herb Baked Chicken Breast

Lean, high-protein, low-sodium. The workhorse recipe you'll make on repeat.

Why it works for Pulmonary Arterial Hypertension Lean protein with minimal saturated fat. Garlic has modest blood pressure-lowering properties.

high-proteinlow-sodiumlow-fat

15 min prep · 15 min cook · Serves 2

Medium

Teriyaki Cauliflower Rice Bowl

All the satisfaction of a rice bowl with a fraction of the carbs. Trust the cauliflower.

Why it works for Pulmonary Arterial Hypertension Low in saturated fat, high in fiber and lean protein.

low-carbblood-sugarhigh-fiber

10 min prep · 25 min cook · Serves 4

Red Lentil & Vegetable Soup

One pot, 30 minutes, feeds four. The kind of meal your whole household will actually eat.

Why it works for Pulmonary Arterial Hypertension Regular legume consumption is associated with lower cardiovascular risk and reduced LDL cholesterol.

high-fiberplant-basedlow-glycemic

15 min prep · 5 min cook · Serves 2

Zucchini Noodles with Walnut Pesto

Pasta vibes, zero guilt. The pesto is the reason to make this.

Why it works for Pulmonary Arterial Hypertension Walnut-based pesto delivers plant-based omega-3s and monounsaturated fats linked to cardiovascular benefit.

low-carbno-cookgluten-free

10 min prep · 0 min cook · Serves 2

Apple, Arugula & Goat Cheese Salad

Light, bright, and kidney-friendly. The apple and arugula combo is genuinely delicious.

Why it works for Pulmonary Arterial Hypertension Polyphenols in apples and walnuts have cardioprotective effects.

low-potassiumno-cookkidney-safe

Medium ⚠️ Med interaction note

10 min prep · 20 min cook · Serves 2

Wild Salmon & Quinoa Power Bowl

A legitimate anti-inflammatory meal that makes you feel like you're doing something right.

Why it works for Pulmonary Arterial Hypertension This is essentially a Mediterranean-style meal — omega-3s, leafy greens, healthy fats. Everything cardiologists recommend.

omega-3complete-proteinanti-inflammatory

5 min prep · 0 min (overnight) cook · Serves 1

Banana & Almond Butter Overnight Oats

Prepare it the night before. Wake up, eat, feel human.

Why it works for Pulmonary Arterial Hypertension Beta-glucan fiber lowers LDL cholesterol. Almond butter adds heart-healthy monounsaturated fats.

gut-friendlyno-cookmeal-prep

Medium ⚠️ Med interaction note

10 min prep · 20 min cook · Serves 2

DASH Diet Quinoa & Veggie Bowl

Built specifically around what the DASH trial actually showed works for blood pressure.

Why it works for Pulmonary Arterial Hypertension Complete plant-based meal with heart-healthy fats from avocado and olive oil.

low-sodiumhigh-potassiumDASH

10 min prep · 40 min cook · Serves 2

Roasted Beet & Goat Cheese Salad

Beets are legitimately one of the best foods for blood pressure. This one just tastes great too.

Why it works for Pulmonary Arterial Hypertension Combined with omega-3 walnuts and anti-inflammatory greens, this is a cardiovascular standout.

blood-pressurenitrate-richheart-healthy

5 min prep · 10 min cook · Serves 1

Spinach & Mushroom Omelette

Quick weekday breakfast that earns its place in a blood pressure diet. High protein, high potassium.

Why it works for Pulmonary Arterial Hypertension Choline in eggs supports cardiovascular function. Spinach provides folate for homocysteine metabolism.

high-proteinlow-sodiumhigh-potassium

10 min prep · 15 min cook · Serves 4

Ground Turkey & Veggie Stir-Fry

Weeknight workhorse. 20 minutes, one pan, no excuses.

Why it works for Pulmonary Arterial Hypertension Lean turkey and colorful vegetables in a sesame-based sauce — minimal saturated fat, maximum nutrients.

high-proteinlow-carbone-pan

5 min prep · 5 min cook · Serves 1

Avocado Toast with Poached Egg

We're not apologizing for the avocado toast. The research on avocados is solid.

Why it works for Pulmonary Arterial Hypertension Avocados are one of the few foods that raise HDL (good cholesterol) while lowering LDL. The monounsaturated fats are extensively studied for cardiovascular benefit.

heart-healthyquickmonounsaturated-fats

15 min prep · 0 min cook · Serves 2

Chickpea Power Salad with Tahini Dressing

This is the salad that makes people stop saying they don't like salads.

Why it works for Pulmonary Arterial Hypertension Mediterranean-style. Chickpeas, tahini, and olive oil are proven components of heart-protective diets.

plant-basedno-cookhigh-fiber

5 min prep · 0 min (overnight) cook · Serves 1

Classic Overnight Oats with Chia

The most effortful thing about this recipe is remembering to make it the night before.

Why it works for Pulmonary Arterial Hypertension Beta-glucan in oats and omega-3 ALA in chia together make this one of the most consistently heart-recommended breakfast options.

meal-prephigh-fiberblood-sugar

10 min prep · 20 min cook · Serves 4

Mediterranean Baked Cod with Olives & Tomatoes

White fish, olives, capers, tomatoes. Mediterranean diet in a baking dish — done in 20 minutes.

Why it works for Pulmonary Arterial Hypertension Lean white fish replaces saturated-fat meat. Olive oil and olives provide heart-protective monounsaturated fats. Low sodium when capers are rinsed.

omega-3low-sodiumlow-phosphorus

10 min prep · 0 min cook · Serves 2

Blueberry, Spinach & Almond Salad

Blue + green is basically the anti-inflammatory color palette. This salad earns that description.

Why it works for Pulmonary Arterial Hypertension Blueberries consistently improve blood pressure and LDL oxidation in clinical trials. Almonds reduce LDL cholesterol. Olive oil provides oleocanthal, which has ibuprofen-like anti-inflammatory effects.

anti-inflammatoryantioxidantno-cook

10 min prep · 35 min cook · Serves 4

Rosemary-Garlic Roasted Chicken Thighs

Chicken thighs are more forgiving than breasts — juicy, flavorful, and ready in 35 minutes. The anti-inflammatory herbs carry this.

Why it works for Pulmonary Arterial Hypertension Skinless chicken thighs are heart-healthy lean protein. Olive oil and garlic provide cardiovascular benefits. Low sodium when salt is minimized.

anti-inflammatoryhigh-proteinkidney-safe

15 min prep · 30 min cook · Serves 6

White Bean & Vegetable Minestrone

Italian grandma energy with a modern anti-inflammatory upgrade. This soup feeds six and gets better the next day.

Why it works for Pulmonary Arterial Hypertension Regular legume consumption is associated with 9–10% lower cardiovascular risk. The combination of plant protein, soluble fiber, and olive oil makes this a heart-protective meal.

anti-inflammatoryhigh-fiberMediterranean

15 min prep · 10 min cook · Serves 4

Steamed White Fish Tacos with Cabbage Slaw

Fish tacos don't have to be fried. Steamed tilapia or cod, crunchy slaw, a bright lime crema. Kidney-safe and genuinely great.

Why it works for Pulmonary Arterial Hypertension White fish is lean protein with minimal saturated fat. Cabbage provides sulforaphane. Corn tortillas provide fiber without the phosphorus additives found in many flour tortillas.

kidney-safelow-potassiumlow-phosphorus

8 min prep · 12 min cook · Serves 4

Lemon-Herb Baked Tilapia

The most kidney-friendly fish on the menu. Quick, flavorful, and completely appropriate for CKD stages 3–5.

Why it works for Pulmonary Arterial Hypertension While lower in omega-3s than salmon, tilapia is still a lean heart-healthy protein. The olive oil and herbs add cardiovascular benefit.

kidney-safelow-phosphorushigh-protein

5 min prep · 5 min cook · Serves 1

Turmeric Golden Milk (Warm Spice Drink)

Ancient remedy, modern validation. Warm, slightly spicy, genuinely calming.

Why it works for Pulmonary Arterial Hypertension Curcumin (the active compound in turmeric) has dozens of clinical trials supporting its anti-inflammatory effects. Black pepper is required for meaningful absorption.

anti-inflammatorywarm-drinkdairy-free-option

10 min prep · 0 min cook · Serves 2

Walnut, Cherry & Arugula Salad

Tart, sweet, and full of things your joints will appreciate.

Why it works for Pulmonary Arterial Hypertension Cherries are one of the few foods shown in clinical trials to reduce uric acid (gout) and muscle soreness after exercise. Walnuts provide plant-based omega-3s.

anti-inflammatoryno-cookantioxidant

5 min prep · 0 min cook · Serves 1

Ginger-Berry Anti-Inflammatory Smoothie

Two minutes, a blender, and your inflammation is about to meet its match.

Why it works for Pulmonary Arterial Hypertension Ginger, turmeric, and berries each independently shown to reduce inflammatory markers (IL-6, CRP). Combined, they're a strong start to the day.

anti-inflammatoryquickno-cook

5 min prep · 0 min cook · Serves 1

Tart Cherry Anti-Inflammatory Smoothie Bowl

Tart cherries are one of the most studied anti-inflammatory foods on the planet. This bowl makes them delicious.

Why it works for Pulmonary Arterial Hypertension Tart cherries contain some of the highest concentrations of anthocyanins of any food. Clinical trials show they reduce markers of inflammation (CRP, IL-6) and can lower uric acid — relevant for gout, lupus, and autoimmune joint conditions.

anti-inflammatoryantioxidantno-cook

10 min prep · 20 min cook · Serves 4

Broccoli & Chickpea Turmeric Curry

Warming, filling, and packed with compounds your immune system will appreciate. Vegan, done in 30 minutes.

Why it works for Pulmonary Arterial Hypertension Broccoli contains sulforaphane — one of the most potent anti-inflammatory compounds in food, shown to activate the Nrf2 pathway. Combined with turmeric and ginger, this curry delivers multiple independent anti-inflammatory mechanisms in a single bowl.

anti-inflammatoryplant-basedhigh-fiber

15 min prep · 40 min cook · Serves 6

Chicken & Wild Rice Anti-Inflammatory Soup

Comfort food with a purpose. Wild rice, ginger, turmeric, and a whole chicken. The soup your joints needed.

Why it works for Pulmonary Arterial Hypertension Wild rice has significantly higher antioxidant content than white or brown rice. Combined with turmeric, ginger, and the collagen from long-simmered chicken, this soup addresses inflammation through multiple channels — joint support, gut lining, and antioxidant intake.

anti-inflammatorygut-friendlyone-pot

⚠️

Food & medication interactions: Some ingredients interact with common medications. Cards marked with a warning badge include notes — always consult your pharmacist or doctor about dietary changes while on medication.

Clinical Trial February 20, 2026

PAH Clinical Trials 2026: Emerging Therapies and What's in the Pipeline

The PAH pipeline in 2026 is advancing on multiple fronts, building on the transformative sotatercept approval to explore disease modification and potentially curative approaches. Key ongoing and recently reported trials: The ZENITH trial is studying sotatercept in WHO FC II patients — earlier in the disease course where modification of vascular remodeling may have maximum impact. The ADVANCE OUTCOMES trial is evaluating sotatercept's effect on morbidity and mortality as a primary endpoint (vs. STELLAR's 6MWT endpoint). Combination of sotatercept with initial triple oral therapy is being explored in investigator-initiated trials. Gene therapy approaches targeting BMPR2 mutations (the most common genetic cause of heritable PAH) are in early clinical development. Ralinepag, a second-generation oral prostacyclin receptor agonist, showed Phase 2 efficacy data. Several trials are examining the role of GDF/activin pathway inhibition beyond sotatercept. Anti-inflammatory and metabolic approaches (metformin in PAH via METPAH; dichloroacetate targeting metabolic reprogramming of pulmonary vascular cells) are in Phase 1/2. The Pulmonary Hypertension Association (PHAssociation.org) maintains a searchable clinical trial database and offers patient matching support for any PAH patient interested in participating.

NIH October 15, 2025

Transplant Evaluation for PAH: When to Refer and What to Expect

Lung transplantation (bilateral lung transplant or combined heart-lung transplant) remains an option for PAH patients who deteriorate despite maximally optimized medical therapy. With the advances in targeted therapy over the past decade, fewer PAH patients progress to transplant — but it remains important to refer early enough to allow time for evaluation and listing. Indicators for transplant referral: rapidly deteriorating WHO FC despite triple combination therapy, significant hemodynamic deterioration (TAPSE <1.5 cm, CI <2 L/min/m², RA pressure >15 mmHg), BNP/NTproBNP continuing to rise, multiple hospitalizations, syncope at rest or with minimal exertion, and pericardial effusion. The Pulmonary Hypertension Association recommends referral when WHO FC III despite 3 months of optimized therapy, or immediately for WHO FC IV. Once listed, median wait time for lung transplantation in the US is 2–4 years, though the Lung Allocation Score (LAS) system prioritizes sicker patients. Five-year survival post-transplant for PAH is approximately 50%, which is lower than transplant for other diagnoses but substantially better than the prognosis of medically refractory advanced PAH. Heart-lung transplant is reserved for patients with significant biventricular failure or uncorrectable congenital cardiac anatomy. Experienced PAH centers — PHA-accredited Pulmonary Hypertension Care Centers — should guide transplant timing decisions.

NIH January 1, 2026

PDE5 Inhibitors and sGC Stimulators in PAH: Sildenafil, Tadalafil, and Riociguat

The nitric oxide-cGMP pathway is one of three major therapeutic targets in PAH. Nitric oxide (NO) normally relaxes pulmonary arterial smooth muscle by increasing intracellular cyclic GMP (cGMP). Two drug classes enhance this pathway: phosphodiesterase-5 inhibitors (PDE5i), which prevent cGMP breakdown, and soluble guanylate cyclase (sGC) stimulators, which directly stimulate cGMP production. Sildenafil (Revatio): The first PDE5i approved for PAH (2005). 20 mg three times daily. The SUPER-1 trial showed significant 6MWD improvement. Generic versions are now widely available, making it the most affordable targeted PAH therapy. Main side effects: headache, flushing, hypotension, visual disturbances. Cannot be combined with nitrates or riociguat (risk of severe hypotension). Tadalafil (Adcirca): Once-daily dosing advantage over sildenafil (40 mg once daily). PHIRST trial showed superior 6MWD improvement vs. placebo. Often preferred for its convenience and successful use in the AMBITION combination trial. Generic available since 2019. Riociguat (Adempas): Stimulates sGC by a mechanism independent of NO availability — effective even in the setting of oxidative stress that degrades NO. Approved for both PAH and inoperable/persistent chronic thromboembolic pulmonary hypertension (CTEPH, Group 4) — the only drug approved for both. The PATENT-1 trial showed significant 6MWD improvement. Riociguat is teratogenic — requires REMS enrollment for women of childbearing potential. It cannot be combined with PDE5 inhibitors.

FDA March 26, 2024

Sotatercept for PAH: A New Mechanism and What the STELLAR Trial Shows

Sotatercept (Winrevair, Merck) received FDA approval in March 2024 — the first truly novel PAH mechanism in over a decade. Unlike existing therapies that target vasoconstriction, sotatercept is an activin signaling inhibitor (fusion protein trapping activin A and other TGF-β ligands) that addresses the aberrant vascular cell proliferation and remodeling underlying PAH. It doesn't just manage symptoms — it targets disease modification at a structural level. The Phase 3 STELLAR trial enrolled 323 WHO FC II-III PAH patients on background PAH therapy and randomized them to sotatercept 0.7 mg/kg subcutaneous every 3 weeks vs. placebo. Results: sotatercept improved 6MWT by 40.8 meters vs. placebo, significantly reduced PVR (the first drug to show meaningful PVR reduction in a Phase 3 trial on background therapy), improved WHO functional class in 36% of patients, and reduced time to death or worsening. BNP and right ventricular strain markers also improved significantly. Sotatercept is administered subcutaneously every 3 weeks by injection (self-administration is possible after training). The main side effects include telangiectasias (spider veins), increased hemoglobin (polycythemia, which may require dose adjustment), and dizziness. It's indicated for adults with PAH WHO Group 1 in combination with other PAH therapies. This addition to the treatment algorithm — a fourth combination partner — represents the most significant advance in PAH pharmacotherapy in years.

NIH December 1, 2025

PAH and Pregnancy: Understanding the Serious Risks

Pregnancy in PAH carries very high maternal mortality — historically estimated at 30–56%, though more recent series from expert centers suggest this may be improving to 10–25% with intensive multidisciplinary management. PAH is considered a contraindication to pregnancy by all major cardiology and obstetrics societies. This is one of the most important counseling points for any woman of reproductive age with PAH. Why pregnancy is dangerous in PAH: The physiological changes of pregnancy — increased cardiac output, increased blood volume, systemic vasodilation — all stress the right ventricle, which is already under severe strain. Labor and delivery create acute hemodynamic shifts. The immediate postpartum period is the highest-risk window, when return of uterine blood volume combined with falling peripheral resistance can precipitate acute right ventricular failure. For women who become pregnant despite this guidance: immediate referral to a PAH center with maternal-fetal medicine co-management is essential. Continuing targeted PAH therapy is critical — abrupt drug discontinuation in pregnancy can be fatal. Delivery planning (timing, mode, anesthesia) must be individualized and performed at a center experienced in managing PAH in pregnancy. Women with PAH who wish to avoid pregnancy should use effective contraception; estrogen-containing contraceptives are relatively contraindicated due to thrombosis risk, making progestin-only methods or non-hormonal options preferable.